Patients with a history of AD or with filaggrin mutations are more likely to develop both allergic and irritant dermatitis; this can explain why there is an increased incidence of eczematous manifestations in those HCWs using PPEs previously suffering of AD. 13. Here, FLG is linked to Alzheimer disease.